Gritstone Oncology (GRTS) PT Lowered to $9 at Barclays
Tweet
Share
E-mailGet Alerts GRTS Hot Sheet
Price: $0.03 --0%
Rating Summary:
7 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 22
Rating Summary:
7 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 22
Join SI Premium – FREE
Barclays analyst Geoff Meacham lowered the price target on Gritstone Oncology (NASDAQ: GRTS) to $9.00 (from $25.00) while maintaining a Overweight rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- ENEOS Holdings Inc (5020:JP) (JXHLY) PT Raised to JPY1,800 at JPMorgan
- Rakuten Inc. (4755:JP) (RKUNF) PT Lowered to JPY900 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
